+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hearing Disorder Drug"

Hearing Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Hearing Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 100 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

The Hearing Disorder Drug market is a subset of the Central Nervous System Drugs market. It includes drugs used to treat hearing loss, tinnitus, and other hearing-related disorders. These drugs are typically administered orally, intravenously, or through the ear. They can be used to improve hearing, reduce tinnitus, and reduce the risk of hearing loss. Common drugs used to treat hearing disorders include aminoglycosides, loop diuretics, and corticosteroids. The Hearing Disorder Drug market is highly competitive, with many companies offering a variety of products. Companies in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, and Bayer. Other companies in the market include Allergan, AstraZeneca, and Teva Pharmaceuticals. Show Less Read more